Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon

Protein boosts heart attack recovery, could be a game-changer for patients

There are approximately 20,000 proteins in the human heart—and one of them, if administered as a drug, could help patients recover more quickly following a myocardial infarction.

FDA approves new fast-acting insulin for type 1 and type 2 diabetes

The approval was based on data from two phase III randomized, treat-to-target studies. 

Infective endocarditis after TAVR: 4 key findings from a new study of 7,000 patients

Infective endocarditis is a relatively rare complication of TAVR, but the infection can be fatal when it does strike.

Thumbnail

Specialists share experience prescribing a historically expensive cardiovascular medication

Tafamidis received FDA approval in May 2019 for the treatment of transthyretin amyloid cardiomyopathy (ATTR-CM). It has a list price of $225,000 per year.

Thumbnail

The top 10 hospitals for pediatric cardiology care

Such attributes as patient outcomes, efficiency and available resources were used to develop the list, which includes a tie at No. 10. 

Thumbnail

Treating type 2 diabetes with ertugliflozin does not increase risk of major cardiovascular events

The VERTIS CV Study tracked the performance of ertugliflozin and a placebo in more than 8,000 adult T2D patients.

Thumbnail

Azithromycin associated with greater risk of cardiovascular death, but not sudden cardiac death

Outpatient prescriptions for azithromycin are associated with an increased risk of cardiovascular mortality, according to new research published in JAMA Network Open.

Thumbnail

Dexamethasone improves outcomes for critically ill COVID-19 patients

Why dexamethasone could be a legitimate game-changer in the fight against COVID-19—and an update on the FDA and hydroxychloroquine.

Displaying 3097 - 3104 of 10791

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.